DAFTAR PUSTAKA
1. Sinatra RS, Jahr JS, Watkins-Pitchford JM, editors. The Essence of Analgesia and Analgesics. Cambridge: Cambridge University Press; 2011. p. 229-231. 2. Laine L. Approaches to nonsteroidal anti-inflammatory drug use in the
high-risk patient. Gastroenterology. 2001; 120:594-606.
3. IMS Health. IMS MIDAS Quantum based on selected markets (ATC = M1A oral solids form only. US$ Actual, growth in US$ CER). Q4. 2008.
4. Kementerian Kesehatan Republik Indonesia. Riset Kesehatan Dasar (RISKESDAS) 2013. Jakarta: Badan Penelitian dan Pengembangan Kesehatan; 2013.
5. Kementerian Kesehatan Republik Indonesia. Riset Kesehatan Dasar (RISKESDAS) 2007. Jakarta: Badan Penelitian dan Pengembangan Kesehatan; 2007.
6. Meinicke J, Danneskiold-Samsøe B. Diclofenac sodium (Voltaren) and ibuprofen in rheumatoid arthritis. A randomized double-blind study. Scand J Rheumatol Suppl. 1980; 35:1-8.
7. Burke A, Smyth E, FitzGerald GA. Analgesic-Antipyretic Agents; Pharmacotherapy of Gout. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman & Gillman’s The Pharmacological Basis of Therapeutics. 12th ed. California: The McGraw Hill Companies; 2011. p. 698.
8. Aronson, JK. Meyler's Side Effects of Analgesics and Anti-inflammatory Drugs. San Diego: Elsevier Science 702; 2010. p. 225-226.
9. Griffin MR, Yared A, Ray WA. Nonsteroidal antiinflammatory drugs and acute renal failure in elderly persons. American Journal of Epidemiology. 2000; 151:488–496.
10. Harris RC. COX-2 and the Kidney. Journals of Cardiovascular Pharmacology. 2006; 47:S37–S42.
12. Koepke JA, Koepke JF. Guide to Clinical Laboratory Diagnosis. Michigan: Appleton & Lange; 1987.
13. Ronco C, Bellomo R, Kellum JA. Critical Nephrology 2nd ed. Philadelphia: Saunders Elsevier; 2009. p. 252-254.
14. Yasmeen T, Qureshi GS, Perveen S. Adverse effects of Diclofenac sodium on renal parenchyma of adult albino rats. Jinnah Postgraduate Medical Journal. 2007; 57(7):349-351.
15. Taib NT, Jarrar BM, Mubarak MM. Ultrastructural Alterations in Renal Tissues of Rabbits Induced by Diclofenac Sodium (Voltaren). Saudi Med J. 2004; 25(10):1360-1365.
16. Aprioku JS, Uche FI. Renal Effects of Non-Steroidal Anti-Inflammatory Drugs in Albino Rats. British Journal of Pharmaceutical Research. 2013; 3(3): 314-325.
17. Payne RB. Tests of Kidney Function. Scientific Foundations of Biochemistry in Clinical Practice. 1994; 325-337.
18. Jacobson RH, Striker EG, Klahrs S. The Principles and Practice of Nephrology. Philadelphia: Decker Inc; 1991.
19. Witjaksono, Villyastuti YW, Sutiyono D. Masalah Nyeri. In: Soenarjo, Jatmiko HD, editors. Anestesiologi ed 2. Semarang: PERDATIN Cabang Jawa Tengah; 2013. hal. 309-321.
20. Dorland. Dorland’s Illustrated Medical Dictionary. 32nd ed. Philadelphia: Elsevier Saunders; 2012. p. 252-254, 403-407.
21. International Association for the Study of Pain. IASP Taxonomy [Internet]. c2015 [updated 2012 May 22; cited 2015 Jan 9]. Available from: http://www.iasp-pain.org/Taxonomy/
22. Bull E, Archard G. Simple Guide Nyeri Punggung. Jakarta: Penerbit Erlangga; 2007. hal. 11.
24. Parnham MJ. Non Opioid Analgesic in the Treatment of Acute Pain. Sweden: Springer Basel AG; 2012.
25. Ganiswarna SG, editor. Farmakologi dan Terapi ed 5. Jakarta: Balai Penerbit FK UI; 2012. hal. 208, 218.
26. Katzung BG. Farmakologi Dasar dan Klinik. Jakarta: Salemba Medika; 2004. hal. 688-689.
27. Witjahjo RBB. Sistem Urinarius. In: Susilaningsih N, Ismail A, Armalina D, Saktini F, editors. Lecture Notes Histologi 2. Semarang: Bagian Histologi Fakultas Kedokteran Universitas Diponegoro; 2012. hal. 68-82.
28. Guyton AC, Hall JE. Buku Ajar Fisiologi Kedokteran Edisi 11. Jakarta: EGC; 2007. hal. 324-326.
29. Van de Graff. Human Anatomy 6th Edition. California: The McGraw Hill Companies; 2001. p. 677.
30. Faiz O, Moffat D. Anatomi at a Glance. Oxford: Blackwell Science; 2002. p. 49.
31. Ellis H. Clinical Anatomy Applied anatomy for students and junior doctors 11th Edition. Oxford: Blackwell Science; 2006. p. 105-107.
32. Anatomy & Physiology [cited 2015 26 Jan]. Available from: http://philschatz.com/anatomy-book/contents/m46429.html.
33. Bagian Anatomi. Systema Urogenital. Semarang: Bagian Anatomi Fakultas Kedokteran Universitas Diponegoro. hal 1-9.
34. Harris RC, Neilson EG. Adaptation of the Kidney to Renal Injury. In: Longo DL, Fauci AS, Loscalzo J, Hauser SL et al, editors. Harrison’s Principle of Internal Medicine. 18th ed. California: The McGraw Hill Companies; 2011. p. 2289.
35. Junqueira LC, Carneiro J. Basic Histology. California: The McGraw Hill Companies; 2002. p. 332-342.
37. Effendi I, Markum HMS. Pemeriksaan Penunjang pada Penyakit Ginjal. In: Sudoyo AW, Setiyohadi B, Alwi I, Simadibrata M, Setiati S, editors. Buku Ajar Ilmu Penyakit Dalam. ed 5. Jakarta: Interna Publishing; 2009. hal. 938. 38. Selim MI. Ammonia, Urea Biosynthesis, Ammonia Intoxication [published
lecture notes]. Available from:
http://osp.mans.edu.eg/medbiochem_mi/Cources/Biochemistry/2nd_year_med icine/Protein_metabolism/files/Lecture_03.htm/
39. Murray RK, Granner DK, Rodwell VW, Mayes PA. Harper’s Illustrated Biochemistry 26th ed. California: The McGraw Hill Companies; 2003. p. 260. 40. Blood Serum Chemistry - Normal Values [Internet]. Maryland: US FDA;
2015 [updated 2015 Jan 8; cited 2015 Jan 12]. Available from: http://www.fda.gov/downloads/ICECI/Inspections/IOM/UCM135835.pdf/ 41. Weir MR. Renal Effects of Nonselective NSAIDs and Coxibs. Cleveland
Clinic Journal of Medicine [Internet]. 2002. [cited 2014 October 4]; 69(1):53. Available from: PubMed.
42. Modi CM, Mody SK, Patel HB, Dudhatra GB, Kumar A, Avale M. Toxicopathological overview of analgesic and anti-inflammatory drugs in animals. Journal of Applied Pharmaceutical Science [Internet]. 2012. [cited 2015 January 8]; 02(01):149-157. Available from: www.japsonline.com. 43. Are cyclooxygenase-2-selective inhibitors safe for the kidneys? Joint Bone
Spine [Internet]. 2013 [cited 2015 January 8]; 70(2013):237-241. Available from: www.sciencedirect.com.
44. Musu M et al. Acute nephrotoxicity of NSAID from the foetus to the adult. European Review for Medical and Pharmacological Sciences [Internet]. 2011 [cited 2015 January 8]; 15(2011):1461-1472. Available from: www.sciencedirect.com.
46. UpToDate [Internet]. NSAID: Acute renal failure and nephrotic syndrome; c2001 [updated 2001 May 10; cited 2015 January 8]. Available from: www.uptodate.com.
47. Naughton CA. Drug-Induced Nephrotoxicity. American Family Physician [Internet]. 2008 [cited 2015 January 8]; 78(6):743-750. Available from: www.aafp.org/afp.
48. Kumar V, Cotran RS, Robbins SL. Buku Ajar Patologi Robbins Volume 1. Jakarta: Penerbit Buku Kedokteran EGC; 2004. hal. 8-9.
49. World Health Organization (WHO). General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine. Geneva: WHO. 2000. 50. Laurence DR et al. Evaluation of Drug Activities. London: Academic Press.
1964.
51. Dilger K et al. Effects of celecoxib and diclofenac on blood pressure, renal function, and vasoactive prostanoids in young and elderly subjects. J Clin Pharmacol [Internet]. 2002 [cited 2015 June 11]: 42(9):985-994. Available from: www.ncbi.nlm.nih.gov/pubmed.
52. Evenepoel P. Acute toxic renal failure. Best Practice & Research Clinical Anaesthesiology [Internet]. 2004 [cited 2015 June 8]: 18(1):37-52. Available from: www.sciencedirect.com.
53. Bolat D, Selcuk ML. Stereological and biochemical evaluation of diclofenac-induced acute nephrotoxicity in rats. Revue Med. Vet. [Internet]. 2013 [cited 2015 January 8]: 164(6):290-294. Available from: www.revmedvet.com. 54. U.S. National Library of Medicine [Internet]. Maryland: U.S. National Library
of Medicine; c1993 [updated 2015 June 19; cited 2015 June 29]. Available from: http://www.nlm.nih.gov.
LAMPIRAN
LAMPIRAN 3. DATA PENELITIAN
Kelompok Tikus Ke- Kadar Ureum (mg/dl)
LAMPIRAN 4. HASIL ANALISIS
Case Processing Summary
Dosis Natrium Diklofenak Cases
Valid Missing Total
Dosis Natrium Diklofenak Statistic Std. Error
Kadar
Ureum .00
Mean 59.3400 3.75694
95% Confidence Interval for
Mean
Lower Bound 48.9091
Upper Bound 69.7709
5% Trimmed Mean 59.3333
Median 60.1000
Variance 70.573
Std. Deviation 8.40077
Minimum 49.90
Maximum 68.90
Range 19.00
Interquartile Range 16.60
Skewness -.071 .913
Kurtosis -2.606 2.000
1.40
Mean 63.8800 6.75954
95% Confidence Interval for
Mean
Lower Bound 45.1125
Upper Bound 82.6475
5% Trimmed Mean 63.5167
Range 34.30
Interquartile Range 28.60
Skewness .669 .913
Kurtosis -2.081 2.000
2.80
Mean 62.8200 4.85112
95% Confidence Interval for
Mean
Lower Bound 49.3511
Upper Bound 76.2889
5% Trimmed Mean 62.8167
Median 65.1000
Interquartile Range 19.20
Test of Homogeneity of Variances
Within Groups 1666.788 12 138.899
Total 1723.197 14
Post Hoc Tests
Multiple Comparisons
Dependent Variable: Kadar Ureum
LSD
Std. Error Sig. 95% Confidence Interval
Lower Bound Upper Bound
LAMPIRAN 6. BIODATA MAHASISWA
Identitas
Nama : Lailitifa Windy Subekti
NIM : 22010111130116
Tempat/tanggal lahir : Kebumen/22 Januari 1994 Jenis Kelamin : Perempuan
Alamat : Dukuh Srasutan, RT 02/01, Desa Ungaran, Kec. Kutowinangun, Kab. Kebumen
Nomor Telepon : -
Nomor HP : 085643308874
e-mail : lailitifawindy@gmail.com
Riwayat Pendidikan Formal
1. SD : SD N 1 Ungaran Lulus tahun: 2005
2. SMP : SMP N 1 Kebumen Lulus tahun: 2008
3. SMA : SMA N 1 Kebumen Lulus tahun: 2011
4. FK UNDIP : Masuk tahun : 2011
Keanggotaan Organisasi
1. Sekretaris As-Syifa Medical Team Tahun 2013 s/d sekarang 2. Staf Bidang Diklat HIMA KU Undip Tahun 2012 s/d 2014 3. Staf Bidang KSKI Rohis KU Undip Tahun 2012 s/d 2014
4. Staf Bidang PMP KSM Undip Tahun 2013 s/d 2014
